v3.25.2
Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Components of (Loss) Income Before Taxes from Continuing Operations

(Loss) income from continuing operations before taxes is comprised of the following components for the years ended December 31, 2024 and 2023 (in thousands):

 

   2024   2023 
   Year Ended December 31, 
   2024   2023 
Domestic  $36   $(806)
Foreign   (12,030)   (24,745)
Loss from continuing operations before taxes  $(11,994)  $(25,551)
Schedule of Benefit (Provision) for Income Taxes from Continuing Operations

The benefit (provision) for income taxes from continuing operations consists of the following (in thousands):

 

   Year Ended December 31, 
   2024   2023 
Current  –  domestic  $(21)  $(2)
Current  –  foreign   803    2,998 
Current  –  total   782    2,996 
Deferred  –  domestic        
Income tax benefit  $782   $2,996 
Schedule of Reconciliation of the (Benefit) Provision for Income Taxes from Continuing Operations with the Amount Computed by Applying the Statutory Federal Tax Rate to Loss Before Income Taxes

A reconciliation of the (benefit) provision for income taxes from continuing operations with the amount computed by applying the statutory federal tax rate to loss from continuing operations before income taxes is as follows (in thousands):

 

   2024   2023 
   Year Ended December 31, 
   2024   2023 
Loss from continuing operations before taxes  $(11,994)  $(25,551)
Income tax expense computed at statutory federal tax rate   (2,527)   (5,366)
Additional research and development tax relief       (5,409)
Loss surrendered to generate R&D credit       4,865 
Change in valuation allowance   2,798    1,261 
Other foreign items   (1,158)   809 
Disallowed expenses and non-taxable income   35    782 
Stock Compensation   30    62 
Foreign items, including change in tax rates, and other        
Other items   40     
Current - total  $(782)  $(2,996)
Schedule of Significant Components of the Entity's Deferred Tax Assets

Significant components of the Company’s deferred tax assets are shown below (in thousands):

 

   2024   2023 
   Year Ended December 31, 
   2024   2023 
Net operating loss and tax credit carryforwards  $59,417   $57,074 
Depreciation, amortization and impairment of property and equipment   39    39 
Stock options   250    210 
Research and development credits        
Right of use asset   (1)   (26)
Lease liability   1    26 
Other   114    - 
Total deferred tax assets   59,820    57,323 
Valuation allowance for deferred tax assets   (59,820)   (57,323)
Net deferred tax assets  $   $